Most drug therapies distribute the agents throughout the entire body, even though the drugs
are typically only needed at specific tissues. This often limits dosage and causes discomfort …

The development of drug delivery systems using nanoparticles as carriers for small and
large therapeutic molecules remains a rapidly growing area of research. The advantages of …

Aptamers are single‐stranded oligonucleotides that bind to targets with high affinity and
selectivity. Their use as molecular recognition elements has emerged as a viable approach …

Aptamers are molecular recognition elements made of nucleic acids. Diverse synthetic
aptamers have been discovered in a large number of SELEX experiments since 1990. This …

The virus like particle (VLP) derived from bacteriophage P22 presents a unique platform for
constructing catalytically functional nanomaterials by encapsulation of enzymes into its …

Virus-like particle (VLP) technology is a promising approach for the construction of novel
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …

Self-assembling biological systems hold great potential for the synthetic construction of new
active soft nanomaterials. Here we demonstrate the hierarchical bottom-up assembly of …

Protein nanoparticles are effective platforms for antigen presentation and targeting effector
immune cells in vaccine development. Encapsulins are a class of protein-based microbial …

New nanocarrier technologies are emerging, and they have great potential for improving
drug delivery, targeting efficiency and bioavailability. Virus-like particles (VLPs) are natural …

The development of an effective immunotherapy is an attractive strategy toward cancer
treatment. Tumor associated carbohydrate antigens (TACAs) are overexpressed on a variety …